To validate these findings, we examined gene expression across independent datasets and observed consistent differential expression of DDIT4, FOXO1, and STAT3 in both osteoporosis and sarcopenia cohorts, confirming their relevance as shared biomarkers. This evidence concerns the gene FOXO1 and sarcopenia.